Bristol-Myers Squibb Gains from Anthropic AI Partnership
Bristol-Myers Squibb sees stock growth following a deal with Anthropic, highlighting the increasing role of AI in pharmaceuticals.
More from this archive
Anthropic’s Claude Code Dominates Startup AI Coding Landscape
A recent survey highlights Anthropic's Claude Code as the go-to AI coding tool for many startups, signaling a…
Anthropic’s Funding Surge Could Elevate Valuation to $900 Billion
Anthropic is on track to secure over $30 billion in funding, potentially reaching a valuation of $900 billion…
Claude Mythos Uncovers 10,000 Software Vulnerabilities in a Month
Anthropic's Claude Mythos has identified over 10,000 software vulnerabilities in just one month, showcasing the consequential impact of…
Anthropic Co-Founder Highlights Existential Risks of AI Development
Jack Clark of Anthropic warns that AI could soon surpass human capabilities and presents existential risks. He urges…
The archive
sorted by latestAnthropic’s Claude Mythos Preview Revolutionizes Cybersecurity Vulnerability Detection
GPUBeat Desk · 2 min
Anthropic’s Claude Mythos Identifies Over 10,000 Software Vulnerabilities in a Month
GPUBeat Desk · 2 min
Zoom’s Anthropic Investment Surges to $1.27 Billion Amid AI Boom
GPUBeat Desk · 2 min
Anthropic Approaches $30 Billion Funding Round, Valuation Surges
GPUBeat Desk · 2 min
AI Crypto Faces Connectivity Challenges Amid Growing Interest
GPUBeat Desk · 2 min